Genus plc (LON:GNS - Get Free Report)'s stock price rose 10.4% on Friday . The company traded as high as GBX 3,228.80 ($43.38) and last traded at GBX 2,760 ($37.08). Approximately 537,394 shares traded hands during mid-day trading, an increase of 141% from the average daily volume of 223,193 shares. The stock had previously closed at GBX 2,500 ($33.59).
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the stock. Shore Capital restated a "buy" rating and set a GBX 2,900 price objective on shares of Genus in a research report on Thursday. Deutsche Bank Aktiengesellschaft increased their price target on shares of Genus from GBX 2,250 to GBX 2,550 and gave the stock a "buy" rating in a report on Tuesday, July 15th. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Genus currently has a consensus rating of "Buy" and a consensus target price of GBX 2,725.
Check Out Our Latest Research Report on Genus
Genus Stock Performance
The firm has a fifty day moving average of GBX 2,438.87 and a 200-day moving average of GBX 2,076.02. The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.12. The stock has a market capitalization of £1.74 billion, a price-to-earnings ratio of -42,661.29, a PEG ratio of 2.87 and a beta of 0.37.
Genus (LON:GNS - Get Free Report) last posted its earnings results on Thursday, September 4th. The company reported GBX 81.80 earnings per share for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. As a group, sell-side analysts anticipate that Genus plc will post 70.9644323 EPS for the current year.
Genus Company Profile
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.